Cognitive Approaches to Early Alzheimer's Disease Diagnosis

Medical Clinics of North America

Volumn 97, Issue 3, 2013, Pages 425-438

  Harrison, John ^a  

^a METIS COGNITION LTD   (United Kingdom)

Author keywords

Alzheimer disease; Cognitive assessment; Dementia screening; Episodic memory; Mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ATTENTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT TOOL; COGNITION; DEPTH PERCEPTION; EARLY DIAGNOSIS; EPISODIC MEMORY; FREE AND CUED SELECTIVE REMINDING TEST; HOPKIN VERBAL LEARNING TEST; HUMAN; IMPLICIT MEMORY; LANGUAGE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; NEUROIMAGING; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; NEUROPSYCHOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; REY AUDITORY VERBAL LEARNING TEST; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; VERBAL MEMORY; WECHSLER MEMORY SCALE LOGICAL MEMORY TEST; WECHSLER MEMORY SCALE VERBAL PAIRED ASSOCIATES TEST; WORKING MEMORY;

AGED; ALZHEIMER DISEASE; ASYMPTOMATIC DISEASES; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84877046305     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.12.014     Document Type: Review

References (49)

1. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
2. Rentz D., Weintraub S. Neuropsychological detection of early Alzheimer's disease. Early diagnosis of Alzheimer's disease 2000, 169-189. Humana Press, Totowa (NJ). L. Scinto, K. Daffner (Eds.).
3. Ashford J.W. Screening for memory disorder, dementia, and Alzheimer's disease. Aging Health 2008, 4(4):399-432.
4. Mendiondo M.S., Ashford J.W., Kryscio R.J., et al. Designing a Brief Alzheimer Screen (BAS). J Alzheimers Dis 2003, 5(5):391-398.
5. Snyder P.J., Jackson C.E., Petersen R.C., et al. Review article: assessment of cognition in mild cognitive impairment: a comparative study. Alzheimers Dement 2011, 7:338-355.
6. Milner B. Physiologie de l'hippocampe. Les troubles de la mémoire accompagnant des lesions hippocampiques bilatérales 1962, 257-272. Centre National de la Recherche Scientifique, Paris. P. Passouant (Ed.).
7. Collie A., Maruff P. An analysis of systems of classifying mild cognitive impairment in older people. Aust N Z J Psychiatry 2002, 36:133-140.
8. Grundman M., Petersen R.C., Ferris S.H. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004, 61:59-66.
9. Gilman S., Koller M., Black R.S., et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005, 64(9):1553-1562.
10. Vellas B., Andrieu S., Sampaio C., et al. Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol 2007, 6(1):56-62.
11. Blackwell A.D., Sahakian B.J., Vesey R., et al. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 2004, 17(1-2):42-48.
12. Darby D., Pietrzak R.H., Fredrickson J., et al. Intra-individual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement 2012, 8(2):95-104.
13. Sahakian B.J., Morris R.G., Evenden J.L., et al. A comparative-study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988, 111:695-718.
14. Walker M.P., Ayre G.A., Perry E.K., et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2000, 11:327-335.
15. Holdnack J., Drozdick L. The Wechsler Memory Scale 2008, Pearson, San Antonio (TX).
16. Barr W., Morrison C., Zaroff C., et al. Use of the Brief Visuospatial Memory Test-Revised (BVMT-R) in neuropsychological evaluation of epilepsy surgery candidates. Epilepsy Behav 2004, 5(2):175-179.
17. Rey A. L'examen psychologique dans les cas d'encéphalopathie traumatique. Les problèmes. Archives de Psychologie 1941, 28:215-285.
18. Damian A.M., Jacobson S.A., Hentz J.G., et al. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord 2011, 31:126-131.
19. Lischka A.R., Mendelsohn M., Overend T., et al. A systematic review of screening tools for predicting the development of dementia. Can J Aging 2012, 31:295-311.
20. Ting C., Rajji T.K., Ismail Z., et al. Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life. PLoS One 2010, 5(4):e10151.
21. Brown L.B., Stern R.A., Cahn-Weiner D.A., et al. Driving scenes test of the neuropsychological assessment battery (NAB) and on-road driving performance in aging and very mild dementia. Arch Clin Neuropsychol 2005, 20:209-215.
22. Fowler K.S., Saling M.M., Conway E.L., et al. Computerized neuropsychological tests in the early detection of dementia: prospective findings. J Int Neuropsychol Soc 1997, 3:139-146.
23. Ferris S.H., Lucca U., Mohs R., et al. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997, 11(Suppl 3):34-38.
24. Harrison J.E., Maruff P. Measuring the mind: assessing cognitive change in clinical drug trials. Exp Rev Clin Pharmacol 2008, 1(4):471-473.
25. Harrison JE. Fighting Alzheimer's disease: can gaming help cut the costs and save the patient? Presented at Games for Health. Amsterdam; November 5, 2012.
26. Robinson-Whelen S., Storandt M. Immediate and delayed prose recall among normal and demented adults. Arch Neurol 1992, 49:32-34.
27. Grober E., Kawas C. Learning and retention in preclinical and early Alzheimer's disease. J Int Neuropsychol Soc 1996, 2:12.
28. Locascio J.J., Growden J.H., Corkin S. Cognitive test performance in detecting, staging and tracking Alzheimer's disease. Arch Neurol 1995, 52:1087-1099.
29. Welsh K.A., Butters N., Hughes J., et al. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991, 48:278-281.
30. Welsh K.A., Butters N., Hughes J.P., et al. Detection and staging of dementia in Alzheimer's disease. Arch Neurol 1992, 49:448-452.
31. Morris J.C., Edland S., Clark C., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993, 43:2457-2465.
32. Eslinger P.J., Damasio A.R. Preserved motor learning in Alzheimer's disease: implications for anatomy and behavior. J Neurosci 1986, 6:3006-3009.
33. Moscovitch M. Multiple dissociations of function in amnesia. Human memory and amnesia 1982, 337-370. Erlbaum, Hillsdale (NJ). L.S. Cermak (Ed.).
34. Price B.H., Gurvit H., Weintraub S., et al. Neuropsychological patterns and language deficits in twenty consecutive cases of autopsy-confirmed Alzheimer's disease. Arch Neurol 1993, 50:931-937.
35. Morris J.C., Fulling K. Early Alzheimer's disease. Arch Neurol 1988, 45:345-349.
36. Kaszniak A.W., Garron D.C., Fox J. Differential effects of age and cerebral atrophy upon span of immediate recall and paired associate learning in older patients with suspected dementia. Cortex 1979, 15:285-295.
37. Trenerry M.R., Crosson B., DeBoe J., et al. Stroop neuropsychological screening test 1989, Psychological Assessment Resources, Odessa (FL).
38. Benton A.L., deS Hamsher K., Varney N.R., et al. Contributions to neuropsychological assessment 1983, Oxford University Press, New York.
39. Reitan R.M. Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 1958, 8:271-276.
40. Grady C.L., Haxby J.V., Horwitz B., et al. A longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer's type. J Clin Exp Neuropsychol 1988, 10:576-596.
41. Grober E., Lipton R.B., Hall C., et al. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000, 54:827-832.
42. Frank R.M., Byrne G.J. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. Int J Geriatr Psychiatry 2000, 15:317-324.
43. Schmidt M. The Rey Auditory Verbal Learning Test 1996, A Handbook Western Psychological Services, Los Angeles (CA).
44. Levinson D., Reeves D., Watson J., et al. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease. Arch Clin Neuropsychol 2005, 20:403-408.
45. Gualtieri C.T., Johnson L.G. Neurocognitive testing supports a broader concept of mild cognitive impairment. Am J Alzheimers Dis Other Demen 2005, 20:359-366.
46. Saxton J., Morrow L., Eschman A., et al. Computer assessment of mild cognitive impairment. Postgrad Med 2009, 121:177-185.
47. Dougherty J.H., Cannon R.L., Nicholas C.R., et al. The Computerized Self Test: an interactive, Internet accessible cognitive screening test for dementia. J Alzheimers Dis 2010, 20:185-195.
48. Shankle W.R., Romney A.K., Hara J., et al. Method to improve the detection of mild cognitive impairment. Proc Natl Acad Sci U S A 2005, 102:4919-4924.
49. Simon ES, Goldstein FC, Lah JJ, et al. Computerized cognitive assessment predicts conversion to dementia within two years: interim analysis of a prospective study of MCI. In: International Conference on the Prevention of Dementia. Washington, DC, June 9-12, 2007.